ADPT

NASDAQ · Life Sciences Tools & Services

Adaptive Biotechnologies

Mid-Cap Stocks Healthcare Stocks

$23.11

+0.54 (+2.39%)

As of Aug 8, 1:33 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 12 86%

Hold 2 14%

Sell 0 0%

Price Target

Analyst Price Target +273.0% upside

Low Target $68.90

Average Target $86.20

High Target $131.13

Current Price $23.11

Current
$23.11

Target
$86.20

$68.90 $86.20 avg $131.13

Scenario Analysis

Bear Case

$68.90

198.1%

Low target

Base Case

$86.20

+273.0%

Avg target

Bull Case

$131.13

+467.4%

High target

Risk/Reward

2.4x

Favorable

Price in Context

52-Week High

$24.96

-7.4% from high

52-Week Low

$10.66

+116.9% from low

50-Day SMA

$16.81

+37.5% vs SMA

200-Day SMA

$13.88

+66.5% vs SMA

RSI (14)

24.2

Oversold

Target vs 52W High

$86.20

+245.4% vs high

Peer Consensus — Life Sciences Tools & Services

Stock	Consensus	Analysts	Buy %	Target	Upside
TMO Thermo Fisher Scientific Inc	Strong Buy	36	81%	$369.21	-37.8%
DHR Danaher Corp	Strong Buy	32	84%	$158.11	-22.8%
A Agilent Technologies Inc	Strong Buy	29	79%	$64.69	-55.7%
WAT Waters Corp	Hold	30	53%	$189.60	-53.4%
IQV Iqvia Holdings Inc	Strong Buy	29	76%	$82.96	-65.2%
ILMN Illumina Inc	Buy	28	61%	$169.36	-9.9%
MTD Mettler-Toledo International	Hold	20	50%	$170.43	-88.1%
WST West Pharmaceutical Services	Strong Buy	22	91%	$136.24	-61.5%